Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

QoL and Patients' Care

Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantation

Abstract

Return to work is critical goal following HSCT. However, late effects may impede return to normal activity after HSCT. In the case of inability to work, patients may need a work disability pension to ensure a reasonable livelihood. This study evaluated inability to work and need for disability pension among long-term survivors and analyzed possible determinants of need for social support. This retrospective, single-center study included all HSCT patients surviving 5 years seen at the outpatient clinic between January 2013 and August 2015. There were 203 patients, median age at HSCT 35 years, and 50 years at time of study; median time between HSCT and study control was 12 years; 178 had allo-HSCT, 187 had a malignant disease. At time of study, 156 (77%) were working full or part-time, 47 (23%) were not working. In total, 76 (37%) survivors were receiving a work disability pension compared to 3.17% of the Swiss working population. Patients with a disability pension were significantly older at HSCT, were more often living alone, had more active physical and mental late effects, and higher score of fatigue compared to patients without. These findings underline the importance of screening for employment and the social consequences of non-employment in long-term survivors after HSCT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Hahn T, McCarthy PL Jr., Hassebroek A, Bredeson C, Gajewski JL, Hale GA et al. Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors. J Clin Oncol 2013; 31: 2437–2449.

    Article  Google Scholar 

  2. Savani BN, Griffith ML, Jagasia S, Lee SJ . How I treat late effects in adults after allogeneic stem cell transplantation. Blood 2011; 117: 3002–3009.

    Article  CAS  Google Scholar 

  3. Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 2007; 110: 3784–3792.

    Article  CAS  Google Scholar 

  4. Martin PJ, Counts GW Jr., Appelbaum FR, Lee SJ, Sanders JE, Deeg HJ et al. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol 2010; 28: 1011–1016.

    Article  Google Scholar 

  5. Sun CL, Kersey JH, Francisco L, Armenian SH, Baker KS, Weisdorf DJ et al. Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study. Biol Blood Marrow Transplant 2013; 19: 1073–1080.

    Article  Google Scholar 

  6. Kirchhoff AC, Leisenring W, Syrjala KL . Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation. J Cancer Surviv 2010; 4: 33–44.

    Article  Google Scholar 

  7. Mehnert A . Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol 2011; 77: 109–130.

    Article  Google Scholar 

  8. Steiner JF, Cavender TA, Main DS, Bradley CJ . Assessing the impact of cancer on work outcomes: what are the research needs? Cancer 2004; 101: 1703–1711.

    Article  Google Scholar 

  9. Khera N, Chang YH, Hashmi S, Slack J, Beebe T, Roy V et al. Financial burden in recipients of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2014; 20: 1375–1381.

    Article  Google Scholar 

  10. Denzen EM, Thao V, Hahn T, Lee SJ, McCarthy PL, Rizzo JD et al. Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study. Bone Marrow Transplant 2016; 51: 1233–1240.

    Article  CAS  Google Scholar 

  11. Löf CM, Winiarski J, Ljungman P, Forinder U . The socioeconomic and psychosocial circumstances of adult long-term survivors of hematopoietic stem cell transplantation in childhood. Pediatr Transplant 2011; 15: 691–698.

    Article  Google Scholar 

  12. de Boer AG, Taskila T, Ojajarvi A, van Dijk FJ, Verbeek JH . Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA 2009; 301: 753–762.

    Article  CAS  Google Scholar 

  13. Stergiou-Kita M, Grigorovich A, Tseung V, Milosevic E, Hebert D, Phan S et al. Qualitative meta-synthesis of survivors' work experiences and the development of strategies to facilitate return to work. J Cancer Surviv 2014; 8: 657–670.

    Article  Google Scholar 

  14. Kiserud CE, Fagerli UM, Smeland KB, Fluge Ø, Bersvendsen H, Kvaløy S et al. Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation. Acta Oncol 2016; 55: 547–553.

    Article  CAS  Google Scholar 

  15. Morrison EJ, Ehlers SL, Bronars CA, Patten CA, Brockman TA, Cerhan JR et al. Employment status as an indicator of recovery and function one year after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2016; 22: 1690–1695.

    Article  Google Scholar 

  16. Federal Statistical Office The Swiss Labour Force Survey 2015 in brief, In: (FDHA) FDoHAeditor. Federal Statistical Office: Neuchâtel, Switzerland, 2016 p. 1–28.

  17. Kirsch M, Mitchell SA, Dobbels F, Stussi G, Basch E, Halter JP et al. Linguistic and content validation of a German-language PRO-CTCAE-based patient-reported outcomes instrument to evaluate the late effect symptom experience after allogeneic hematopoietic stem cell transplantation. Eur J Oncol Nurs 2015; 19: 66–74.

    Article  Google Scholar 

  18. National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. DCTD, NCI, NIH, NHHS, (acccessed on 29 May 2009).

  19. National Cancer Institute. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0. DCTD, NCI, NIH, DHHS, (accessed on 9 August 2006).

  20. Bresters D, van Gils IC, Kollen WJ, Ball LM, Oostdijk W, van der Bom JG et al. High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study. Bone Marrow Transplant 2010; 45: 79–85.

    Article  CAS  Google Scholar 

  21. Schmid B, Buri M . Statistiken zur Sozialen Sicherheit: IV- Statistik 2014, In: BfSB Statistik (eds). Eidgenössisches Departement des Inneren EDI: Bern, Switzerland, 2015 pp. 1–43.

    Google Scholar 

  22. Bieri S, Roosnek E, Helg C, Verholen F, Robert D, Chapuis B et al. Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant 2008; 42: 819–827.

    Article  CAS  Google Scholar 

  23. Winterling J, Johansson E, Wennman-Larsen A, Petersson LM, Ljungman P, Alexanderson K . Occupational status among adult survivors following allo-SCT. Bone Marrow Transplant 2014; 49: 836–842.

    Article  CAS  Google Scholar 

  24. Atkinson TCB, Marllier E, Nolan B Social Indicatores The EU and Social Inclusion. Oxford University Press: Oxford. UK, 2002. d.

    Book  Google Scholar 

  25. Federal Statistical Office. Recipents of means-tested social benefits. Federal administration, Federal Department of Home Affairs.2014 Available at https://www.bfs.admin.ch/bfs/en/home/statistics/social-security/social-assistance/recipients-means-tested-social-benefits.html.

  26. eurostat Statisics Explained. Social protection statistics-pension expenditure and pension beneficiaries2016. Available at http://ec.europa.eu/eurostat/statistics-explained/index.php/Social_protection_statistics_-_pension_expenditure_and_pension_beneficiaries-Data_sources_and_availability.

  27. Karlsson NE, Carstensen JM, Gjesdal S, Alexanderson KA . Mortality in relation to disability pension: findings from a 12-year prospective population-based cohort study in Sweden. Scand J Public Health 2007; 35: 341–347.

    Article  Google Scholar 

  28. Bjorkenstam C, Alexanderson K, Bjorkenstam E, Lindholm C, Mittendorfer-Rutz E . Diagnosis-specific disability pension and risk of all-cause and cause-specific mortality—a cohort study of 4.9 million inhabitants in Sweden. BMC Public Health 2014; 14: 1247.

    Article  Google Scholar 

  29. Wallman T, Wedel H, Johansson S, Rosengren A, Eriksson H, Welin L et al. The prognosis for individuals on disability retirement. An 18-year mortality follow-up study of 6887 men and women sampled from the general population. BMC Public Health 2006; 6: 103.

    Article  Google Scholar 

  30. Head J, Ferrie JE, Alexanderson K, Westerlund H, Vahtera J, Kivimaki M et al. Diagnosis-specific sickness absence as a predictor of mortality: the Whitehall II prospective cohort study. BMJ 2008; 337: a1469.

    Article  Google Scholar 

  31. Popham F, Skivington K, Benzeval M . Why do those out of work because of sickness or disability have a high mortality risk? Evidence from a Scottish cohort. Eur J Public Health 2013; 23: 629–635.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Alicia Rovó for her careful reading of the manuscript and her meaningful critical comments and suggestions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A Tichelli.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tichelli, A., Gerull, S., Holbro, A. et al. Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant 52, 1436–1442 (2017). https://doi.org/10.1038/bmt.2017.115

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2017.115

This article is cited by

Search

Quick links